Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes

Diabetologia

Volumn 50, Issue 11, 2007, Pages 2366-2373

  Straczkowski, M ^a   Kowalska, I ^a   Baranowski, M ^a   Nikolajuk, A ^a   Otziomek, E ^a   Zabielski, P ^a   Adamska, A ^a   Blachnio, A ^a   Gorski, J ^a   Gorska, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Insulin sensitivity and resistance; Lipid metabolism; Obesity; Weight regulation

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; DIACYLGLYCEROL; LONG CHAIN FATTY ACID; SPHINGANINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MEASUREMENT; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; CERAMIDES; DIABETES MELLITUS, TYPE 2; HUMANS; LIPIDS; MALE; MUSCLE, SKELETAL; REFERENCE VALUES; RISK FACTORS; SPHINGOMYELINS;

EID: 34848921862     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0781-2     Document Type: Article

References (42)

1. Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788
2. Pan DA, Lillioja S, Kriketos AD et al (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988
3. Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119
4. Perseghin G, Scifo P, De Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes 48:1600-1606
5. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671
6. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
7. Summers SA, Nelson DH (2005) A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54:591-602
8. Dobrzyn A, Gorski J (2002) Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Am J Physiol 282:E277-E285
9. 3 pituitary cells. J Biol Chem 262:16759-16762
10. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick RN (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414
11. Wertz PW, Downing DT (1990) Ceramidase activity in porcine epidermis. FEBS Lett 268:110-112
12. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72
13. Schmitz-Pfeiffer C, Craig DL, Biden TJ (1999) Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210
14. Stratford S, Hoehn KL, Liu F, Summers SA (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of akt/protein kinase B. J Biol Chem 279:36608-36615
15. Chavez JA, Holland WL, Bar J, Sandhoff K, Summers SA (2005) Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 280:20148-20153
16. Rahman SM, Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Ntambi JM (2003) Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci USA 100:11110-11115
17. Dobrzyn A, Dobrzyn P, Lee SH et al (2005) Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol 288:E599-E607
18. Pinnamanemi SK, Southgate RJ, Febbraio MA, Watt MJ (2006) Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49:3027-3037
19. Watt MJ, Hevener A, Lancaster GI, Febbraio MA (2006) Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 147:2077-2085
20. Turpin SM, Lancaster GI, Darby I, Febbraio MA, Watt MJ (2006) Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol 291:E1341-E1350
21. Straczkowski M, Kowalska I, Nikolajuk A et al (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53:1215-1221
22. Adams JM, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31
23. Helge JW, Dobrzyn A, Saltin B, Gorski J (2004) Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 89:119-127
24. Bruce CR, Thrush AB, Mertz VA et al (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol 291:E99-E107
25. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM (2006) Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis: thiazolidinedione treatment reverses these defects. Diabetes 55:2277-2285
26. Turinsky J, O'Sullivan DM, Bayly BP (1990) 1,2-Diacylglycerol and ceramide levels in insulin resistant tissues of the rat in vivo. J Biol Chem 265:16880-16885
27. Itani SI, Ruderrman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011
28. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
29. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
30. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5:600-608
31. Liu B, Hassler DF, Gary KS, Weaver K, Hannun YA (1998) Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J Biol Chem 273:34472-34479
32. Nikolova-Karakashian M, Merrill AH Jr (2000) Ceramidases. Methods Enzymol 311:194-201
33. Dobrzyn A, Gorski J (2002) Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat. Horm Metab Res 34:523-529
34. Van der Vusse GJ, Roemen TH, Reneman RS (1980) Assessment of fatty acids in dog left ventricular myocardium. Biochim Biophys Acta 617:43-49
35. Duncombe WS (1964) The colorimetric microdetermination of nonesterified fatty acids in plasma. Clin Chim Acta 9:122-135
36. Chavez JA, Knotts TA, Wang LP et al (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
37. Serlie MJ, Meijer AJ, Groener JE et al (2007) Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 92:1524-1529
38. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101-109
39. Gorska M, Dobrzyn A, Zendzian-Piotrowska M, Gorski J (2004) Effect of streptozotocin-diabetes on the functioning of the sphingomyelin signaling pathway in skeletal muscles of the rat. Horm Metab Res 36:14-21
40. Gorska M, Baranczuk E, Dobrzyn A (2003) Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm Metab Res 35:506-507
41. Pickersgill L, Litherland GJ, Greenberg AS, Walker M, Yeaman SJ (2007) Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 282:12583-12589
42. Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated fat-, and obesity-induced insulin resistance. Cell Metab 5:167-179